The National Retail Federation, the nation’s largest retail trade group, expects holiday sales to actually exceed growth seen in prior seasons, even amid all the uncertainty surrounding the pandemic.
Indiana on Monday issued its weekly COVID-19 data for schools. The state said more than 1,755 schools have reported one or more cases, 220 schools have reported zero cases and 391 schools have provided no data.
AstraZeneca is the third major drug company to report late-stage results for a potential COVID-19 vaccine as the world anxiously waits for scientific breakthroughs that will bring an end to a pandemic.
The acceleration of coronavirus cases is causing an existential crisis for America’s retailers and spooking their customers just as the critically important holiday shopping season nears.
Promising news about a coronavirus vaccine has small business owners feeling more upbeat. They also realize many hurdles remain as the pandemic shows no signs of abating heading into the winter.
More than 2 million people were screened at U.S. airports on Friday and Saturday, according to the Transportation Security Administration. Friday was only the second time since mid-March that daily airport screenings topped 1 million.
The Indiana State Department of Health on Sunday reported 6,255 new COVID-19 cases, the 12th straight day that the state has reported more than 5,000 new cases.
It is the second drug of this type—called a monoclonal antibody—to be cleared for COVID-19. The FDA authorized Eli Lilly and Co.’s drug on Nov. 9.
The state on Saturday reported 40 new COVID-19 deaths, raising the cumulative total during the pandemic to 4,992.
The pandemic has reshaped the most important shopping season of the year, forcing retailers to rethink inventory, store layouts and when, even how, they offer their deepest discounts.
U.S. Treasury Secretary Steven Mnuchin said a decision to end several emergency loan programs being run by the Federal Reserve was based on the fact that the programs were not being heavily utilized.
COVID-19 patients occupy nearly 42% of Indiana’s intensive care beds. The state said only 21.6% of its ICU beds are unoccupied.
In a separate development, the FDA on Thursday gave emergency authorization to use of another anti-inflammatory drug sold by Eli Lilly, baricitinib, to be used with remdesivir.
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Without data to paint a picture of academic success or failure, Indianapolis Public Schools will likely delay for a year renewing the contracts of four privately run schools under its supervision.
The CDC issued the recommendations just one week before Thanksgiving, at a time when diagnosed infections, hospitalizations and deaths are skyrocketing across the country.
Tyson Foods suspended top officials at its largest pork plant on Thursday and launched an investigation into allegations that they bet on how many workers would get infected during a widespread coronavirus outbreak.
The central bank said it “would prefer that the full suite of emergency facilities established during the coronavirus pandemic continue to serve their important role as a backstop for our still-strained and vulnerable economy.”
The Indianapolis drugmaker said Thursday evening it was awarded an emergency use authorization for its drug baricitinib to be used in combination with Gilead Sciences’ antiviral drug remdesivir in severely ill, hospitalized patients with COVID-19.
Phase III trials are now accumulating the data needed to report results as a renewed surge of the pandemic hits countries around the world.
